CLASS II Drug recall · Reported 15 Mar 2023 · FDA Enforcement Report

Heparin Sodium, 25,000USP units recalled by B. Braun Medical

B. Braun Medical is recalling Heparin Sodium, 25,000USP units per, (100 USP units per mL) in 5% Dextrose Injection, distributed nationwide in the US. The recall was initiated on 1 Mar 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot J2C017; Expiration: 9/30/2023.
NDC0264-9567, 0264-9577, 0264-9587
Quantity recalled30672

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0434-2023
FDA event ID
91769
Recalling firm
B. Braun Medical, Irvine, CA
Manufacturer
B. Braun Medical Inc.
Classification
Class II
Status
Terminated
Recall initiated
1 Mar 2023
FDA classified
6 Mar 2023
Reported
15 Mar 2023
Customers notified by
Letter
Reason category
Potency & Assay
Drug class
Blood Thinners

Timeline

1 Mar 2023Recall initiated by company
6 Mar 2023Classified by FDA+5 days
15 Mar 2023Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: low Anti-Factor IIa potency.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.Braun Medical Inc, Bethlehem, PA. 18018-3524 USA. NDC 0264-9587-20.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Subpotent Drug: low Anti-Factor IIa potency.

Which lots are affected?

Lot J2C017; Expiration: 9/30/2023.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from B. Braun Medical

All 447

Other Heparin recalls

All 22